Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates

Financial Performance - Nuwellis, Inc. reported a quarterly loss of $0.65 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.43, representing an earnings surprise of -51.16% [1] - The company's revenues for the quarter ended December 2024 were $2.32 million, missing the Zacks Consensus Estimate by 7.12%, and down from $2.55 million in the same quarter last year [2] - The current consensus EPS estimate for the upcoming quarter is -$0.30 on revenues of $2.65 million, and for the current fiscal year, it is -$0.89 on revenues of $12.13 million [7] Stock Performance - Nuwellis shares have increased approximately 13.5% since the beginning of the year, contrasting with a decline of -4.5% in the S&P 500 [3] - The company currently holds a Zacks Rank 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Outlook - The Medical - Instruments industry, to which Nuwellis belongs, is currently ranked in the top 34% of over 250 Zacks industries, suggesting a favorable outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Nuwellis' stock performance [5]